Literature DB >> 3548987

Comparison of diflunisal and naproxen in the treatment of tennis elbow.

P A Stull, P Jokl.   

Abstract

The authors favor conservative treatment of tennis elbow, starting with cessation of the offending activity and prescription of a nonsteroidal anti-inflammatory drug (NSAID) and followed by isometric and isotonic exercises when pain and inflammation have subsided. Two NSAIDs, diflunisal and naproxen, were evaluated in 38 patients with mild-to-moderate pain associated with tennis elbow. The physicians' assessments found no statistically significant differences between the two drugs; both provided effective reduction of pain and swelling. Patients' assessments of pain relief achieved with their respective drugs significantly (P = 0.019) favored diflunisal. Prompt and effective relief of pain and swelling hastens the patient's progression to physical therapy and return to normal activities.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3548987

Source DB:  PubMed          Journal:  Clin Ther        ISSN: 0149-2918            Impact factor:   3.393


  5 in total

Review 1.  The efficacy of nonsteroidal anti-inflammatory drugs in the treatment of ligament injuries.

Authors:  L C Almekinders
Journal:  Sports Med       Date:  1990-03       Impact factor: 11.136

Review 2.  A rational management of tennis elbow.

Authors:  M Kamien
Journal:  Sports Med       Date:  1990-03       Impact factor: 11.136

Review 3.  Naproxen. A reappraisal of its pharmacology, and therapeutic use in rheumatic diseases and pain states.

Authors:  P A Todd; S P Clissold
Journal:  Drugs       Date:  1990-07       Impact factor: 9.546

4.  Pragmatic randomised controlled trial of local corticosteroid injection and naproxen for treatment of lateral epicondylitis of elbow in primary care.

Authors:  E M Hay; S M Paterson; M Lewis; G Hosie; P Croft
Journal:  BMJ       Date:  1999-10-09

Review 5.  Non-steroidal anti-inflammatory drugs (NSAIDs) for treating lateral elbow pain in adults.

Authors:  Porjai Pattanittum; Tari Turner; Sally Green; Rachelle Buchbinder
Journal:  Cochrane Database Syst Rev       Date:  2013-05-31
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.